CA2358895A1 - Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists - Google Patents

Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists Download PDF

Info

Publication number
CA2358895A1
CA2358895A1 CA002358895A CA2358895A CA2358895A1 CA 2358895 A1 CA2358895 A1 CA 2358895A1 CA 002358895 A CA002358895 A CA 002358895A CA 2358895 A CA2358895 A CA 2358895A CA 2358895 A1 CA2358895 A1 CA 2358895A1
Authority
CA
Canada
Prior art keywords
compound
dihydro
vasopressin
methanone
pyrido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002358895A
Other languages
English (en)
French (fr)
Inventor
Robert John Steffan
Amedeo Arturo Failli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2358895A1 publication Critical patent/CA2358895A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA002358895A 1999-02-04 2000-01-13 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists Abandoned CA2358895A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24468199A 1999-02-04 1999-02-04
US09/244,681 1999-02-04
PCT/US2000/000886 WO2000046225A2 (en) 1999-02-04 2000-01-13 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists

Publications (1)

Publication Number Publication Date
CA2358895A1 true CA2358895A1 (en) 2000-08-10

Family

ID=22923710

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002358895A Abandoned CA2358895A1 (en) 1999-02-04 2000-01-13 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists

Country Status (6)

Country Link
EP (1) EP1149097A2 (de)
JP (1) JP2002536375A (de)
CN (1) CN1339035A (de)
AU (1) AU2849600A (de)
CA (1) CA2358895A1 (de)
WO (1) WO2000046225A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201005623D0 (en) 2010-04-01 2010-05-19 Vantia Ltd New polymorph
WO2016089830A1 (en) * 2014-12-05 2016-06-09 Merck Sharp & Dohme Corp. Novel tricyclic compounds as inhibitors of mutant idh enzymes
WO2016089833A1 (en) 2014-12-05 2016-06-09 Merck Sharp & Dohme Corp. Novel tricyclic compounds as inhibitors of mutant idh enzymes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849735A (en) * 1995-01-17 1998-12-15 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
AU8592598A (en) * 1997-07-30 1999-02-22 Wyeth Tricyclic vasopressin agonists

Also Published As

Publication number Publication date
WO2000046225A3 (en) 2000-12-14
AU2849600A (en) 2000-08-25
CN1339035A (zh) 2002-03-06
EP1149097A2 (de) 2001-10-31
WO2000046225A2 (en) 2000-08-10
JP2002536375A (ja) 2002-10-29

Similar Documents

Publication Publication Date Title
US6194407B1 (en) Tricyclic pyrido vasopressin agonists
US6090803A (en) Tricyclic vasopressin agonists
US6344451B1 (en) Pyrrolobenzodiazepine carboxyamide vasopressin agonists
US7329653B2 (en) Cyclohexylphenyl vasopressin agonists
US6620807B1 (en) Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
US6297234B1 (en) Arylthiophene vasopressin agonists
EP1000059B1 (de) Trizyclische vasopressin agoniste
US6235900B1 (en) Tricyclic pyridine N-oxides vasopressin agonists
EP1149104B1 (de) Pyrrolobenzodiazepine carboxamide vasopressin agonisten
CA2358895A1 (en) Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
EP1149096B1 (de) Trizyclische pyridin n-oxide vasopressin agonisten
EP1520855B1 (de) Thieno¬2,3-B pyridin-derivate als Antagonisten des Gonadotropin-freisetzenden Hormons
MXPA01007918A (en) Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
WO2000046227A1 (en) Thienylbenzoylbenzazepines as vasopressin agonists
MXPA01007919A (es) Agonistas de vasopresina de carboxiamidas pirrolobenzodiazepinas
MXPA01007916A (en) Thienylbenzoylbenzazepines as vasopressin agonists
MXPA00000749A (en) Tricyclic vasopressin agonists

Legal Events

Date Code Title Description
FZDE Dead